These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1331448)

  • 21. Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8.
    Pena A; Murat B; Trueba M; Ventura MA; Wo NC; Szeto HH; Cheng LL; Stoev S; Guillon G; Manning M
    J Med Chem; 2007 Feb; 50(4):835-47. PubMed ID: 17300166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of vasopressin and oxytocin receptors in the rat uterus and vascular tissue.
    Anouar A; Clerget MS; Durroux T; Barberis C; Germain G
    Eur J Pharmacol; 1996 Jul; 308(1):87-96. PubMed ID: 8836636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and opioid activity of side-chain-to-side-chain cyclic dynorphin A-(1-11) amide analogues cyclized between positions 2 and 5. 1. Substitutions in position 3.
    Vig BS; Murray TF; Aldrich JV
    J Med Chem; 2004 Jan; 47(2):446-55. PubMed ID: 14711314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design of peptide oxytocin antagonists with strikingly higher affinities and selectivities for the human oxytocin receptor than atosiban.
    Manning M; Cheng LL; Stoev S; Wo NC; Chan WY; Szeto HH; Durroux T; Mouillac B; Barberis C
    J Pept Sci; 2005 Oct; 11(10):593-608. PubMed ID: 15880385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential use of oxytocin and vasopressin V1a antagonists in the treatment of preterm labour and primary dysmenorrhoea.
    Akerlund M; Melin P; Maggi M
    Adv Exp Med Biol; 1995; 395():595-600. PubMed ID: 8714023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel ligands lacking a positive charge for the delta- and mu-opioid receptors.
    Schiller PW; Berezowska I; Nguyen TM; Schmidt R; Lemieux C; Chung NN; Falcone-Hindley ML; Yao W; Liu J; Iwama S; Smith AB; Hirschmann R
    J Med Chem; 2000 Feb; 43(4):551-9. PubMed ID: 10691681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of an orally active, nonpeptidyl oxytocin antagonist.
    Pettibone DJ; Clineschmidt BV; Kishel MT; Lis EV; Reiss DR; Woyden CJ; Evans BE; Freidinger RM; Veber DF; Cook MJ
    J Pharmacol Exp Ther; 1993 Jan; 264(1):308-14. PubMed ID: 8423533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lysine vasopressin-induced increases in porcine myometrial contractility and intracellular Ca2+ concentrations of myometrial cells: involvement of oxytocin receptors.
    Yu H; Zhuge R; Hsu WH
    Biol Reprod; 1995 Mar; 52(3):584-590. PubMed ID: 7756452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasopressin receptors in human pregnant myometrium and decidua: interactions with oxytocin and vasopressin agonists and antagonists.
    Ivanisevic M; Behrens O; Helmer H; Demarest K; Fuchs AR
    Am J Obstet Gynecol; 1989 Dec; 161(6 Pt 1):1637-43. PubMed ID: 2557763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-activity relationships of cyclic pentapeptide endothelin A receptor antagonists.
    Fukami T; Nagase T; Fujita K; Hayama T; Niiyama K; Mase T; Nakajima S; Fukuroda T; Saeki T; Nishikibe M
    J Med Chem; 1995 Oct; 38(21):4309-24. PubMed ID: 7473559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of orally active oxytocin antagonists: studies on 1-(1-[4-[1-(2-methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl]piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and related pyridines.
    Bell IM; Erb JM; Freidinger RM; Gallicchio SN; Guare JP; Guidotti MT; Halpin RA; Hobbs DW; Homnick CF; Kuo MS; Lis EV; Mathre DJ; Michelson SR; Pawluczyk JM; Pettibone DJ; Reiss DR; Vickers S; Williams PD; Woyden CJ
    J Med Chem; 1998 Jun; 41(12):2146-63. PubMed ID: 9622556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progress in the development of oxytocin antagonists for use in preterm labor.
    Pettibone DJ; Guidotti M; Harrell CM; Jasper JR; Lis EV; O'Brien JA; Reiss DR; Woyden CJ; Bock MG; Evans BE
    Adv Exp Med Biol; 1995; 395():601-12. PubMed ID: 8714024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-activity studies of a novel bicyclic oxytocin antagonist.
    Smith DD; Slaninova J; Hruby VJ
    J Med Chem; 1992 May; 35(9):1558-63. PubMed ID: 1578481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SK&F 105494, a V2-vasopressin receptor antagonist, blocks oxytocin receptors in porcine myometrium.
    Yu H; Hsu WH
    Zhongguo Yao Li Xue Bao; 1996 Jul; 17(4):365-8. PubMed ID: 9812726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analogues of a potent oxytocin antagonist with truncated C-terminus or shorter amino acid side chain of the basic amino acid at position 8.
    Flouret G; Chaloin O; Slaninová J
    J Pept Sci; 2003 Jun; 9(6):393-401. PubMed ID: 12846485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of annetocin, an oxytocin-related peptide isolated from the earthworm Eisenia foetida, and some putative neurotransmitters on gut motility of the earthworm.
    Ukena K; Oumi T; Matsushima O; Ikeda T; Fujita T; Minakata H; Nomoto K
    J Exp Zool; 1995 Jun; 272(3):184-93. PubMed ID: 7790842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutagenesis at the human tachykinin NK(2) receptor to define the binding site of a novel class of antagonists.
    Meini S; Bellucci F; Catalani C; Cucchi P; Patacchini R; Rotondaro L; Altamura M; Giuliani S; Giolitti A; Maggi CA
    Eur J Pharmacol; 2004 Mar; 488(1-3):61-9. PubMed ID: 15044036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of a D-Cys6/L-Cys6 interchange in nonselective and selective vasopressin and oxytocin antagonists.
    Manning M; Cheng LL; Klis WA; Balaspiri L; Olma A; Sawyer WH; Wo NC; Chan WY
    J Med Chem; 1995 May; 38(10):1762-9. PubMed ID: 7752199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design of oxytocin antagonists, which are more selective than atosiban.
    Manning M; Stoev S; Cheng LL; Wo NC; Chan WY
    J Pept Sci; 2001 Sep; 7(9):449-65. PubMed ID: 11587184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of functional oxytocin receptors in lactating rat mammary gland in vitro.
    Pettibone DJ; Woyden CJ; Totaro JA
    Eur J Pharmacol; 1990 Apr; 188(4-5):235-41. PubMed ID: 2163875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.